Catalyst Wire Dossier Catalyst Wire Dossier

Docetaxel-PNP

docetaxel-polymeric nanoparticle formulation · Samyang Biopharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Docetaxel-PNP, covering 2017-05-01 to 2017-05-05. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies [Phase 1]

See pricing